We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.57M
Cap. Flow %
-2.89%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

Rank Stock Value
1
XFLT
XAI Floating Rate & Alternative Income Trust
XFLT
+$689K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
+$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
+$468K
4
ENIC icon
Enel Chile
ENIC
+$430K
5
EFT
Eaton Vance Floating-Rate Income Trust
EFT
+$429K

Top Sells

Rank Stock Value
1
GRA
W.R. Grace & Co.
GRA
+$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
+$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
+$693K
4
NOA
North American Construction
NOA
+$554K
5
MCI
Barings Corporate Investors
MCI
+$524K

Sector Composition

Rank Sector Weight
1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLW icon
151
BlackRock Limited Duration Income Trust
BLW
$492M
$463K 0.2%
27,120
+624
+2% +$10.7K
CERE
152
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$462K 0.2%
15,667
-817
-5% -$22.9K
GAIN icon
153
Gladstone Investment Corp
GAIN
$648M
$460K 0.2%
33,138
-3,812
-10% -$55.3K
VVR icon
154
Invesco Senior Income Trust
VVR
$456M
$457K 0.2%
102,698
-2,381
-2% -$10.4K
DVAX
155
DELISTED
Dynavax Technologies
DVAX
$453K 0.2%
23,572
-1,227
-5% -$16.3K
KDMN
156
DELISTED
Kadmon Holdings, Inc.
KDMN
$448K 0.2%
51,476
-2,686
-5% -$15.3K
NBIX icon
157
Neurocrine Biosciences
NBIX
$17.7B
$441K 0.19%
4,594
-418
-8% -$39.5K
MAIN icon
158
Main Street Capital
MAIN
$5B
$437K 0.19%
10,643
-610
-5% -$25.4K
EVF
159
Eaton Vance Senior Income Trust
EVF
$90.1M
$434K 0.19%
61,624
-492
-0.8% -$3.36K
DCPH
160
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$431K 0.19%
12,686
-1,160
-8% -$37K
HALO icon
161
Halozyme
HALO
$9.66B
$429K 0.19%
10,551
-964
-8% -$40.3K
BMRN icon
162
BioMarin Pharmaceuticals
BMRN
$11.6B
$428K 0.19%
5,544
-510
-8% -$40.2K
VRTX icon
163
Vertex Pharmaceuticals
VRTX
$122B
$426K 0.19%
2,350
-213
-8% -$41.6K
CLDX icon
164
Celldex Therapeutics
CLDX
$2.8B
$425K 0.19%
7,865
-435
-5% -$20.4K
EFT
165
Eaton Vance Floating-Rate Income Trust
EFT
$284M
$425K 0.19%
+29,196
New +$429K
EXEL icon
166
Exelixis
EXEL
$14B
$425K 0.19%
20,097
-1,840
-8% -$34.2K
INSM icon
167
Insmed
INSM
$22.7B
$420K 0.18%
15,261
-1,399
-8% -$36.7K
QNCX icon
168
Quince Therapeutics
QNCX
$17.5M
$410K 0.18%
22
-2
-8% -$31.8K
FOLD
169
DELISTED
Amicus Therapeutics
FOLD
$407K 0.18%
42,669
-3,907
-8% -$40K
IONS icon
170
Ionis Pharmaceuticals
IONS
$9.25B
$406K 0.18%
12,102
-1,110
-8% -$41.8K
OMER icon
171
Omeros
OMER
$821M
$406K 0.18%
29,436
-2,694
-8% -$40.3K
VNDA icon
172
Vanda Pharmaceuticals
VNDA
$314M
$406K 0.18%
23,693
-2,177
-8% -$38.1K
BCRX icon
173
BioCryst Pharmaceuticals
BCRX
$2.43B
$404K 0.18%
28,090
-2,579
-8% -$40.7K
AMGN icon
174
Amgen
AMGN
$203B
$402K 0.18%
1,891
-179
-9% -$41.2K
RARE icon
175
Ultragenyx Pharmaceutical
RARE
$2.65B
$401K 0.18%
4,450
-403
-8% -$36.4K
5 6
7
8 9

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Virtus ETF Advisers held 407 positions worth $227M, down 6.5% from $243M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.4%. Virtus ETF Advisers opened 8 new positions and exited 10, leaving the 407-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Real Estate and Energy.

  • Virtus ETF Advisers's largest Q3 2021 buy was XAI Floating Rate & Alternative Income Trust: 15,447 shares worth $663K.
  • Virtus ETF Advisers added most to Enel Chile in Q3 2021, an estimated $430K increase.
  • Virtus ETF Advisers's biggest Q3 2021 reduction was North American Construction, cutting an estimated $554K.
  • Virtus ETF Advisers fully exited W.R. Grace & Co. in Q3 2021, selling an estimated $1.73M.
  • Virtus ETF Advisers's ten largest holdings make up 7.9% of its $227M portfolio in Q3 2021.
  • Virtus ETF Advisers opened 8 new positions and closed 10 in Q3 2021.
  • Virtus ETF Advisers's portfolio value fell 6.5% quarter-over-quarter to $227M.

Based on Virtus ETF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.